Mesenchymal stem cell therapies: The quest for fine-tuning

Experimental Dermatology

Volumn 23, Issue 9, 2014, Pages 632-633

  Goodrich, Angelina Daisy ^a   Hematti, Peiman ^b  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Immune modulation; Mesenchymal stem cells; Mesenchymal stem cells heterogeneity

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; PROCEDURES;

HUMANS; IMMUNOTHERAPY, ADOPTIVE; MESENCHYMAL STEM CELL TRANSPLANTATION;

EID: 84921896281     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12432     Document Type: Note

References (12)

1. Nemeth K. Exp Dermatol 2014: doi: 10.1111/exd.12459 [Epub ahead of print].
2. Hunefeld C, Mezger M, Kern J S et al. Exp Dermatol 2013: 22: 162-167.
3. Dieckmann C, Renner R, Milkova L et al. Exp Dermatol 2010: 19: 697-706.
4. Lau K, Paus R, Tiede S et al. Exp Dermatol 2009: 18: 921-933.
5. Khosrotehrani K. Exp Dermatol 2013: 22: 307-310.
6. Hanson S E, Bentz M L, Hematti P. Plast Reconstr Surg 2010: 125: 510-516.
7. Viswanathan S, Keating A, Deans R et al. Stem Cells Dev 2014: 23: 1157-1167.
8. Lorenz K, Sicker M, Schmelzer E et al. Exp Dermatol 2008: 17: 925-932.
9. Hematti P. Cytotherapy 2012: 14: 516-521.
10. Suarez-Alvarez B, Baragano R A, Ortega F et al. Epigenetics 2013: 8: 694-702.
11. Galipeau J. Cytotherapy 2013: 15: 2-8.
12. Mendicino M, Bailey A M, Wonnacott K et al. Cell Stem Cell 2014: 14: 141-145.